Assessment of Neutrophil-to-Lymphocyte Ratio as A Prognostic Marker in Locally Advanced Head and Neck Cancer Treated with Concomitant Chemoradiation Cover

.blurhash-client-img { display: none !important; }

Assessment of Neutrophil-to-Lymphocyte Ratio as A Prognostic Marker in Locally Advanced Head and Neck Cancer Treated with Concomitant Chemoradiation

Forum of Clinical Oncology

Volume 13 (2022): Issue 3 (December 2022)

By: Elisha Servorip Targain, Ashok Chauhan, Diptajit Paul, Shailley Arora Sehgal, Abhishek Soni and Paramjeet Kaur

Open Access

|Oct 2023

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/fco-2023-0004 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X

Journal RSS Feed

Language: English

Page range: 15 - 22

Submitted on: Mar 22, 2023

|

Accepted on: Jul 19, 2023

|

Published on: Oct 27, 2023

Published by: Helenic Society of Medical Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

Chemoradiation,

head and neck cancer,

neutrophil-to-lymphocyte ratio,

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology

© 2023 Elisha Servorip Targain, Ashok Chauhan, Diptajit Paul, Shailley Arora Sehgal, Abhishek Soni, Paramjeet Kaur, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 13 (2022): Issue 3 (December 2022)Next article